CoronaVac
Sinovac vaccine against COVID-19
Facts
8 properties- Subclass of
- COVID-19 vaccine, inactivated vaccine[7][8]
- Described by source
- Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19), Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19), Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial, Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals, A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia[10][11][12][13][14]
- Developer
- Sinovac Biotech, Instituto Butantan, Bio Farma[4][5][6]
- Funder
- Sinovac Biotech[16]
- Manufacturer
- Sinovac Biotech[3]
- Route of administration
- intramuscular injection[9]
🏷️ Also known as
en PiCoVacc
en Sinovac vaccine
en Sinovac COVID-19 vaccine
en Chinese coronavirus vaccine
en Chinese vaccine
en CoronaVac
ar كورونافاك
cs vakcína od Sinovac
cs čínská vakcína
es vacuna china
es vacuna de China
es vacuna Sinovac
es vacuna Sinovac COVID-19
fa کروناواک
hu kínai védőoltás
hu Sinovac védőoltás
ja コロナバック
nl Chinees Coronavirusvaccin
nl Chinees vaccin
nl Chinese CoronaVac-vaccin
🔖 Identifiers · 4
- Image (Wikimedia Commons)
- SINOVAC COVID-19 vaccine.jpg ↗
- ATC code
- J07BX03
- DrugBank ID
- DB15806
- Google Knowledge Graph ID
- /g/11k1mhvnh9
🔗 Connections
← Uses 4
Developer 3
Subclass of 2
Funder 1
Instance of 1
Manufacturer 1
Route of administration 1
Vaccine for 1
← Has use 1
Press Enter · cited answer in seconds
0 sources
Summary
CoronaVac is a funded product[1].